The Cigna Group reported third quarter net income of nearly $2 billion despite rising costs in the health plans it sells.

The stock market pummeled Cigna after the company revealed its new plan to ditch pharmacy benefit rebates will lower that ...

Cigna on Monday announced a new drug-pricing arrangement in which discounts it negotiates with manufacturers will be passed ...

The company said that profit margins for its pharmacy-benefit-services division would slide over the next two years.

Overall, Cigna expects earnings to grow next year after posting a solid third quarter. But investments in a new PBM model and ...

The Cigna Group (NYSE:CI) on Thursday reported third-quarter earnings that exceeded analyst expectations, but shares in the global health company fell sharply after CEO David Cordani warned of profit ...

For those paying the full cost of medications, the new model will reduce the monthly cost for brand-name prescriptions by an ...

Cigna Group on Thursday warned of margin pressure over the next two years as its pharmacy benefit management business ...

Cigna Group’s announcement that it will end the highly criticized practice of accepting back-end drug manufacturer rebates ...

Cigna Group executives stood firm Thursday on eliminating drug rebates as the best route forward for the entire industry.

The Cigna Group is reaffirming its outlook for the year after posting $1.9 billion in profit for the third quarter. | The ...

The Cigna Group reported third quarter net income of nearly $2 billion despite rising costs in the health plans it sells. Like many of its rival health insurers, Cigna has been battling rising medical ...